Our Curriculum
Our Curriculum
We generate and disseminate new knowledge in pharmacotherapy and accelerate its application to improve patient care through:
- Delivering innovative education and training
- Integrating experimental and clinical pharmacology discoveries into the practice of precision medicine
- Unique collaborations with industry, regulatory agencies, renowned health science centers, and international entities
- Leading and participating in local, state, national and international organizations, communities, and programs.
- Engaging students in innovative clinical and translational research
Tracks for Clinicians and Non-Clinicians
The concentration area in pharmacotherapy and experimental therapeutics was developed with two curricular tracks based on previous experience of the applicant:
- Clinician track is for students with a Pharm.D. or M.D., or equivalent
- Nonclinician track is for highly motivated, exceptionally qualified students lacking previous clinical training
Both tracks play a critical part in our mission to educate and develop clinical and translational scientists, and graduates from both tracks have enjoyed an outstanding employment rate in both academia and the pharmaceutical industry.
Curriculum
Ph.D. Program Accreditation
An internal self-study of the School’s graduate program occurs every eight years, with the last self-study occurring in 2016. This information is used to inform the program review process within the University.
The graduate program in Pharmaceutical Sciences (M.S. and Ph.D.) is reviewed as part of the University’s accreditation process every ten years by the Southern Association of Colleges and Schools Commission on Colleges.
The Program Review at UNC-Chapel Hill is outlined at The Graduate School.